Year Outlook Slightly Exceeds Expectations

ZoomInfo (NASDAQ: GTM) reported Q2 CY2026 revenue of $310.4 million, up 1.2% year on year, beating Wall Street expectations. Next-quarter revenue guidance had a $299.5 million midpoint, 1.6% above estimates. Non-GAAP EPS was $0.28, 5.8% above consensus. The article also cites billings of $295.8 million and 1,891 enterprise customers.

Original reporting
Published Aug 5, 2026, 9:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 5, 2026, 9:44 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Year Outlook Slightly Exceeds Expectations — source image
Decision brief

The 30-second read

$GTMBullishMed
01

Why it matters

Traders can update near-term expectations using the specific Q2 revenue/EPS beats and the next-quarter revenue midpoint guidance, while weighing liquidity risk signals from flat billings and guided sales decline.

02

Market read

A concrete earnings-and-guidance print for ZoomInfo with a positive immediate reaction, tempered by management’s next-quarter sales decline and non-growing billings.

03

What to watch

Enterprise customer count (1,891 paying over $100k) is cited, but the article does not quantify churn, net retention, or contract duration, which could explain the billings mismatch.

Relevance 7/10Novelty 6/10Timing: after-hours/next-session positioning following Q2 results and next-quarter guidance

Background

The piece frames ZoomInfo’s Q2 performance versus Wall Street expectations and discusses longer-term growth deceleration and billings quality.

Company-level read

Ticker impact

$GTMBullishMedium confidence
Context

ZoomInfo beat Q2 revenue expectations to $310.4M and guided next-quarter revenue to $299.5M at the midpoint, above estimates.

Expected impact

Likely supports a modest upward bias versus pre-report expectations, with downside risk if investors focus on billings stagnation and guided sales decline.

Evidence & confidence

The article provides concrete Q2 beat, midpoint guidance, and non-GAAP EPS outperformance, but also flags billings not growing and management guiding a year-on-year sales decline next quarter.

Market effects

Reinforces that B2B sales-intelligence software demand is slowing, with investors likely scrutinizing billings quality and guidance direction.

Primarily US software sentiment; limited direct regional spillover beyond growth-software tape.

Low global relevance; mostly affects US-listed software and sales-tech peer sentiment.

Counterpoint

The beat may be less durable because billings failed to grow and management is guiding a year-on-year sales decline next quarter, suggesting the revenue outperformance could be timing-related.

Key entities

  • ZoomInfo

    RevOS revenue intelligence platform; reported Q2 revenue and guidance, plus billings and enterprise customer metrics.

Related articles

$GTMMed

GTM Q2 Deep Dive: Upmarket Focus and Hybrid Pricing Strategy Take Center Stage

ZoomInfo (NASDAQ:GTM) reported Q2 CY2026 revenue of $310.4 million, up 1.2% year over year, beating expectations. Midpoint Q3 revenue guidance was $299.5 million, 1.6% above estimates. Non-GAAP EPS was $0.28, 5.8% above consensus. Management cited upmarket growth, 20% growth in its operations/data business, and a transition to hybrid consumption-based pricing plus AI products like GTM.AI.

$GTMHigh

ZoomInfo Technologies Inc. (GTM): Results of Operations and Financial Condition

ZoomInfo Technologies Inc. (GTM) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 gtm-8kex991x20260805.htm EX-99.1 Document Exhibit 99.1 ZoomInfo Announces Second Quarter 2026 Financial Results VANCOUVER, Wash. , August 5, 2026 - ZoomInfo (NASDAQ: GTM), the all-in-one AI GTM platform, today announced its financial results for the second quarter ended

$GTMMed

GTM Investment Deadline: ZoomInfo Securities Fraud Class Action Focuses on AI Integration Issues; Investors Notified of August 24 Court Deadline

Bleichmar Fonti & Auld LLP said a securities fraud class action was filed against ZoomInfo Technologies (NASDAQ:GTM) and executives after the stock fell about 33% in May 2026. The suit alleges ZoomInfo misled investors about how its AI products affected customer retention and cut 2026 revenue guidance to $1.185–$1.205B. Investors can seek lead-plaintiff status by Aug. 24, 2026.

$GTMMedAI 8/10

ZoomInfo (GTM) Launches Native App Inside OpenAI Codex for Work

ZoomInfo said OpenAI made ZoomInfo natively available inside OpenAI Codex for Work, a B2B data and go-to-market intelligence app. ZoomInfo stated OpenAI selected it to bring verified company intelligence, contacts, and go-to-market signals into Codex so users can run its skills via natural language. Separately, analysts at Morgan Stanley and JPMorgan cut price targets after lower free cash flow and fiscal 2026 outlook.

$GTMMedAI 9/10

Is ZoomInfo Technologies Inc. (GTM) One of the Best Tech Stocks Under $5 to Buy?

Jefferies downgraded ZoomInfo (GTM) to Hold from Buy on May 21, cutting its price target to $4 from $12 and citing a “material” reduction in projected 2026 revenue growth plus no improvement expected in 2027. The firm said client demand has been weak for two years and AI is changing purchasing behavior. Morgan Stanley on May 19 cut its target to $5 from $9, keeping Equal Weight.

$DTMedAI 8/10

Dynatrace Springs on Q1 Figures

Dynatrace (NYSE: DT) reported Q1 FY2027 results for the quarter ended June 30, 2026. Total ARR was $2,136 million, up 17%. Total revenue rose to $555 million, up 16%. Subscription revenue was $530 million. GAAP operating income was $71 million and non-GAAP $162 million. CEO Rick McConnell cited 41% organic net new ARR growth and accelerating TTM growth.